Table 3.
Secondary outcomes
| Carbetocin (n = 150) | Syntometrine (n = 150) | Mean difference | RR | 95% CI | |
|---|---|---|---|---|---|
| Mean blood loss (ml)* | 232 (122) | 249 (175) | −17 | — | −51 to 18 |
| Primary postpartum haemorrhage** | 6 (4) | 3 (2) | — | 2.00 | 0.50–8.32 |
| Blood loss ≥ 500 ml** | 6 (4) | 2 (1.3) | — | 3.00 | 0.61–15.53 |
| Blood loss ≥ 1000 ml** | 0 | 1 (0.7) | — | — | — |
| Repeat oxytocic injection** | 13 (8.7) | 10 (6.7) | — | 1.30 | 0.56–3.13 |
| Need of blood transfusion** | 5 (3.3) | 2 (1.3) | — | 2.50 | 0.49–13.36 |
| Manual removal of placenta** | 1 (0.7) | 3 (2) | — | 0.33 | 0.03–3.20 |
| Mean duration of third stage* (minutes) | 11.6 (17.4) | 10.4 (4.2) | 1.2 | — | −1.7 to 4.1 |
| Duration of third stage (minutes)** | |||||
| ≤10 | 128 (85.3) | 126 (84) | — | 1.02 | 0.59–2.08 |
| 11–30 | 21 (14) | 23 (15.3) | — | 0.91 | 0.47–1.71 |
| >30 | 1 (0.7) | 1 (0.7) | — | 1 | 0.06–16.14 |
*
Data are presented as mean (SD).
**
Data are presented as n (%).